KLRS · Categories · Form 3

KLRS - SEC Form 3 initial insider statements

Kalaris Therapeutics Inc. (KLRS) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for KLRS

• 22d
  SEC Form 3 filed by new insider Keating Laurie

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 29d
  New insider Vandekop Amy O'Leary claimed ownership of 948 shares (SEC Form 3)

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 36d
  SEC Form 3 filed by new insider Bayko Liisa Ann

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 295d
  SEC Form 3 filed by new insider Gall Matthew

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 509d
  SEC Form 3 filed by new insider Patterson Leone D

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)

Other KLRS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends